Year: 2000
Type: review
Abstract: Hodgkin's disease is divulging its secrets at last. Despite the fact that Hodgkin's disease was the first lymphoma to be recognized as a distinct clinical entity ([1][1]), it has proved to be one of the most difficult lymphomas to approach molecularly. The clonal, malignant Hodgkin/Reed-Sternberg (H
Author: Louis M. Staudt
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2147013585
